HopeStage
Back to all studies
WithdrawnNCT03061136

Clonazepam Effects on Brain Oscillations and Cognition in Schizophrenia

Medication studyAges 18–55United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 55 years.

Listed locations
Palo AltoSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateOctober 2016
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
Palo Alto Veterans Institute for Research
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT03061136
Official title
Show the full official title

Clonazepam Effects on Brain Oscillations and Cognition in Schizophrenia

Recruitment & locations

Withdrawn

Palo Alto

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Palo Alto Veterans Institute for Research, a research institute.

Does this study involve medication?

Yes. The study involves medication, including Clonazepam and Placebo.

Who can participate?

Listed age limits: 18 years to 55 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies